Reaction
Immune Reconstitution Inflammatory Syndrome Associated Tuberculosis reporting signals
As of the last recalculation, Immune Reconstitution Inflammatory Syndrome Associated Tuberculosis appears in 329 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is PYRAZINAMIDE (PRR 2,339.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pyrazinamide | 169 | 2,339.6 | 2,382.7 |
| Isoniazid | 162 | 1,245.3 | 1,257.9 |
| Rifampin | 99 | 613.3 | 617.5 |
| Efavirenz | 57 | 391.0 | 393.0 |
| Rifampicin | 46 | 334.2 | 335.8 |
| Tenofovir Disoproxil Fumarate Tablets | 38 | 314.7 | 316.1 |
| Lamivudine Oral | 70 | 222.1 | 222.7 |
| Lamivudine | 73 | 191.8 | 192.3 |
| Nevirapine | 19 | 141.3 | 141.6 |
| Moxifloxacin | 26 | 126.7 | 126.9 |
| Tenofovir Disoproxil Fumarate | 47 | 104.8 | 104.9 |
| Moxifloxacin Hydrochloride | 30 | 102.9 | 103.1 |
| Raltegravir | 20 | 81.5 | 81.6 |
| Itraconazole | 14 | 79.2 | 79.3 |
| Darunavir | 16 | 70.3 | 70.4 |
| Ritonavir 100 Mg | 15 | 66.5 | 66.6 |
| Linezolid | 28 | 64.9 | 65.0 |
| Amphotericin B | 11 | 57.4 | 57.5 |
| Zidovudine | 11 | 53.8 | 53.9 |
| Adalimumab-Fkjp | 34 | 51.7 | 51.7 |
| Adalimumab-Aaty | 34 | 50.6 | 50.6 |
| Abacavir Sulfate | 7 | 46.4 | 46.5 |
| Emtricitabine And Tenofovir Alafenamide | 4 | 22.6 | 22.6 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 15 | 21.8 | 21.8 |